The Cost of Untreated ADHD: What It Can Take From a Child, an Adult, and a Family

ADHD can affect learning, confidence, work, relationships, safety, and daily life. Early, careful care can help change the path.

ADHD rarely sends a bill. Its cost may appear as homework tears, a student giving up, an adult losing a job, or a couple arguing about forgotten tasks. These costs can build for years.

The hardest cost may be the story a person starts to believe: “I am lazy. I am careless. I always fail.” That story is often wrong. ADHD is a health condition. It is not a lack of effort, love, intelligence, or good parenting.

Research links ADHD with problems in school, work, friendships, safety, and daily life. Yet no study can predict one person’s future. Care, support, and personal strengths can change what happens next.

Key takeaways

• ADHD affects brain systems used for attention, action, planning, and self-control.
• Without useful care, repeated struggles may harm learning, confidence, relationships, and family life.
• Some costs are physical. Research links ADHD with more accidental injuries and more car crashes, and links treatment with fewer of both.
• ADHD is often missed in girls, in quiet children, and in adults. More than half of U.S. adults with an ADHD diagnosis were not diagnosed until adulthood.
• Most children with ADHD have at least one other condition, so a good evaluation checks for more than ADHD.
• Treatment is personal. It may include education, behavior support, school help, therapy, skills training, medicine, or a mix of these.

Zoom

A brain that is still building its control system

ADHD stands for attention-deficit/hyperactivity disorder. It is a developmental condition. A person may have trouble holding attention, stopping an impulse, sitting still, or organizing a task. Symptoms begin in childhood, appear in two or more settings, and get in the way of school, work, or social life. Some people mainly struggle with attention. Others are more active or impulsive. Many have both.1

The prefrontal cortex sits behind the forehead. It helps us hold facts in mind, plan steps, resist distractions, and pause before we act. It works with many other parts of the brain. During childhood and the teen years, this whole control system is still developing.

Brain cells talk through chemical messengers. Dopamine and norepinephrine help tune the prefrontal networks used for attention, behavior, and emotion. Either too little or too much of these signals markedly impairs prefrontal function. So ADHD is not a simple shortage of one chemical. A 2024 review looked at both human and animal studies. It found limited evidence that low dopamine by itself defines ADHD. It found changes in only some people with the condition.34

Brain scans show differences only as group averages. One study scanned 223 children with ADHD and 223 without. It tracked the age when half the cortex reached peak thickness. That age was about 10.5 years in the ADHD group. It was about 7.5 years in the other group. The delay was most prominent in prefrontal regions.5

A much larger 2024 study pooled six data sets covering 1,696 youths with ADHD and 6,737 without. It found differences in how deeper brain areas connect with the cortex, and it described those differences as small. The largest effect size was 0.15. The authors wrote that this kind of scan can capture only a fraction of the complex biology of ADHD. No brain scan diagnoses ADHD in one person.6

This science gives us a better message. A child with ADHD is not choosing to be difficult. An adult with ADHD is not choosing to forget. The person is trying to manage real tasks with a control system that may need more support.

The cost to a child and a student

School asks children to use the very skills ADHD can weaken. They must listen, remember directions, begin work, track time, shift between tasks, and turn work in. A bright child may know the answer but fail to show what they know.

Imagine Maya, a made-up student. She understands the lesson. Then she misses a direction, loses a paper, and forgets a book. Her work is late, so adults tell her to try harder. The next day, she is worried before class begins.

One bad day does not define a child. But the same cycle, repeated for months, can create a learning gap. One review pooled 114 long-term studies. In it, children with ADHD were about 3.7 times as likely as other children to not finish high school. It also found higher later rates of depression and arrest. These were links, not proof that ADHD caused each result. The researchers said plainly that their analysis could not determine the mechanisms behind the associations. Learning disorders, sleep, stress, family resources, and access to care also matter.7

The cost can reach beyond grades. Children with ADHD may hear “pay attention,” “wait,” or “why did you forget again?” many times a day. Over time, a child may stop raising a hand, avoid hard work, or hide missing tasks.

A 2024 review found lower self-esteem in young people with ADHD in three areas. They rated themselves lower overall, at school, and with other people. It found no difference in how they judged their own behavior. The authors concluded that these young people do not hold a completely negative view of themselves. Confidence is worth protecting, and it is not automatically lost.8

Friendships can suffer too. Interrupting, missing a social cue, reacting fast, or forgetting plans may upset other children. One review covered 109 studies and more than 100,000 children. The largest difference showed up in peer relationships. It was larger than the difference in social skills or in reading social situations.9 A second review found that children and youth with ADHD had fewer friends and lower-quality friendships. Nearly all of those studies looked at one point in time, so they cannot show what causes what.10

These problems can change the mood at home. Mornings become rushed. Homework fills the evening. Parents may disagree about rules, and siblings may feel left out. A meta-analysis found more parenting stress in families of children with ADHD than in families with no clinical condition. It found something else worth holding onto. Those parents reported no more stress than parents of other children referred to a clinic for any reason. Co-occurring conduct problems and parents’ own depressive symptoms predicted the stress more than ADHD alone.11

The cost grows as life asks for more

As students get older, adults provide fewer reminders. A teen or college student must plan long projects, choose what matters first, and recover from mistakes. Inattention can be easy to miss when the student is quiet. A 2025 review pooled 15 studies of college students. ADHD went with lower grades, and inattention symptoms especially. The studies measured ADHD and grades in different ways. The review did not combine them into one number. So the size of the effect is still uncertain.12

An untreated teen may look careless when they are overwhelmed. Missed work can close doors to classes, training, or a first job. Shame may also stop the student from asking for help.

The adult cost: executive function in daily life

ADHD does not always end at age 18. Adult life adds duties while removing much of the structure school once gave. A person may need to manage work, bills, health visits, children, a home, and relationships at the same time.

“Executive function” is the set of skills used to guide action toward a goal. It includes working memory, self-control, planning, time sense, and changing course when a plan fails. One review of adults with ADHD found moderate average differences in several of these skills. Those included word finding, stopping a response, and shifting between rules. The same authors noted that the difficulties may not be limited to executive function. A later review pooled 34 meta-analyses across all ages. It found an average difference of about 0.45 across many thinking skills. No single skill stood out as the one problem. No one test explains any one person.1314

“Overall function” means how well a person manages life as a whole. It includes work, home, social ties, health, and basic duties. The World Health Organization surveyed 26,744 adults across 20 countries. Current adult ADHD averaged 2.8 percent. It was tied to lost days, harder thinking, and strained social contact. That held even after researchers accounted for other mental health conditions. Treatment seeking was low in every country. When adults did get care, it usually targeted a different condition rather than the ADHD.15

Imagine Daniel, another made-up example. He cares about his work and family. He underestimates how long tasks will take. He misses a deadline, pays a late fee, and forgets an errand. His partner sees broken promises. Daniel sees proof that he cannot be trusted. Neither view tells the full story.

Work, money, and relationships

At work, ADHD may show up as late starts, missed details, lost items, unfinished reports, or quick choices. One review covered 19 long-term studies. It found links with less education, lower job level, and more job instability. It also found weaker job performance, lower income, and more reliance on public aid. The same review found very little research on what actually helps at work.16 A second review looked at whether childhood ADHD predicts holding steady work later. It found weaker attachment to the labor market and rated the overall level of evidence as poor.17 The exact long-term cost is hard to measure.

Money problems may grow from late bills, lost papers, missed work, or impulse buying. One study followed 604 people, 364 with childhood ADHD and 240 without, for nearly 20 years. At age 30, the childhood ADHD group did worse on most financial measures. Their income also grew more slowly between ages 25 and 30. This held even for people who no longer reported ADHD symptoms. The authors also projected, using census data, that men in the ADHD group would earn far less over a working lifetime. That projection describes a group, not a person, and a projection is not a measurement.18

In close relationships, symptoms can look personal. A partner may read forgetting as a lack of care. The person with ADHD may feel judged or controlled. A review found that adults with ADHD tend to have shorter and more discordant romantic relationships. The same review said that little research has identified what actually strengthens those relationships.19

ADHD may also affect parenting. A meta-analysis of 32 studies linked a parent’s ADHD symptoms with slightly harsher parenting, slightly looser rules, and slightly less warmth. The numbers are small. Parents’ ADHD symptoms explained about 3 percent of the difference in harsh parenting. They explained about 3 percent in lax parenting. They explained less than 1 percent in warm parenting. This is added strain, not proof that a person with ADHD is a bad parent.20

The costs that do not show up on a report card

Some costs of ADHD are physical. They deserve plain numbers and no drama.

Accidental injuries. A meta-analysis of 28 studies, covering more than 350,000 people with ADHD, found about 1.5 times the odds of unintentional injury. The same team pooled only the studies that compared people with ADHD to themselves during medicated and unmedicated periods. Injuries were roughly 12 percent lower during medicated periods.21

Driving. A Swedish study followed 17,408 adults with ADHD. Their rate of serious transport accidents was about 1.5 times the rate in adults without ADHD. Then the researchers compared each person with himself, month by month. That kind of comparison is useful. Each person becomes his own control, so steady traits like personality and driving habits cannot explain the result. Among men, months on medication carried a 58 percent lower accident rate than months off it. The same comparison in women did not show a clear difference, and the study held far fewer women to measure. A U.S. study of 2.3 million patients ran the same kind of within-person comparison for emergency visits after crashes. Crash-related visits were 38 percent lower for men and 42 percent lower for women during medication months. The authors estimated that up to 22 percent of these crashes might have been avoided with steady treatment.2223

Substance use. Childhood ADHD is linked with higher later rates of nicotine dependence, cannabis use, and alcohol or drug problems. Some of that link may be driven by co-occurring conduct problems rather than ADHD itself.24 Many parents ask whether stimulant medicine makes this worse. One review pooled 15 long-term studies. Treated and untreated groups had similar later substance use. Stimulant treatment neither protected against that risk nor raised it.25 A later study of nearly 3 million people found fewer substance-related emergency visits during medication periods than during off periods.26

Early death. A Danish study followed 1.92 million people. Among people with ADHD, the death rate was about 5.85 per 10,000 person-years. Among people without ADHD, it was about 2.21. Read that as roughly 6 deaths per 10,000 people per year compared with 2. The relative risk doubles. The absolute risk stays low. Accidents were the most common cause. Risk was highest among people first diagnosed as adults.27 A 2024 Swedish study was built to imitate a clinical trial. Two-year death rates were lower among people who started ADHD medicine: 39.1 per 10,000 compared with 48.1. The difference sat in deaths from accidents, overdose, and suicide.28

Honesty matters more than a clean story here. A 2025 study followed 148,581 people. Starting ADHD medicine went with fewer first events of suicidal behavior, substance misuse, transport accidents, and crime. It did not find a real drop in first accidental injury.29 None of these studies is a randomized trial. People start and stop medicine for reasons that are hard to measure. Here is the honest summary. Treatment is linked with lower risk across several safety outcomes. The size of that benefit differs from one outcome to the next.

Who gets missed

A cost can only be paid for a condition that someone notices.

Girls and women. National guidance in the United Kingdom is direct about this. ADHD is thought to be under-recognized in girls and women. They are less likely to be sent for an assessment. They are more likely to have ADHD that no one has named. They are also more likely to be given the wrong diagnosis instead.30 A 2026 study followed 89,587 children to age 18. Among those who used a health service for ADHD, the middle age at the first visit was 13.6 years for girls. For boys it was 9.4 years.31

Quiet children. The mainly inattentive type is the most common one in the general population. Yet children who are also hyperactive are the ones more likely to be sent for services.32 One study gave 212 primary school teachers a written case to read. When the girl in the case had inattentive symptoms, only 14 percent recognized ADHD. When the case included hyperactivity, 43 percent did. Nearly all the teachers saw that something was wrong. Most called it an attention problem or an emotional problem.33

Adults. A 2023 national survey found that 6.0 percent of U.S. adults, about 15.5 million people, had a current ADHD diagnosis. Of those adults, 55.9 percent were not diagnosed until age 18 or later. At the time of the survey, 36.5 percent were getting no treatment at all. Access is its own problem. Among adults who had filled a stimulant prescription that year, 71.5 percent had trouble getting it because it was unavailable.34 A late diagnosis is common, and it is not a failure.

What often travels with ADHD

ADHD usually does not arrive alone. In the 2022 National Survey of Children’s Health, 77.9 percent of U.S. children aged 3 to 17 with current ADHD had at least one other diagnosed condition:

• behavior or conduct problems: 44.1 percent
• anxiety: 39.1 percent
• learning disability: 36.5 percent
• developmental delay: 21.7 percent
• depression: 18.9 percent
• speech or language disorder: 14.8 percent
• autism: 14.4 percent

These are parent-reported diagnoses rather than fresh clinical assessments, so read them as a map of what commonly co-occurs.35

The picture in adults looks similar. One large health system reviewed 59,371 adults with ADHD. Over the study period, 65.8 percent also had a recorded anxiety disorder, and 57.1 percent had a depressive disorder. Those figures come from diagnoses recorded in one insured population across ten years, not from a national snapshot.36

This is why an evaluation that checks only for ADHD is an incomplete evaluation. The American Academy of Pediatrics guideline tells clinicians to screen for three groups of conditions. Emotional and behavioral ones, such as anxiety, depression, and substance use. Developmental ones, such as learning disorders and autism. Physical ones, such as tics and sleep apnea.37

What “untreated” really means

Untreated ADHD does not simply mean “no medicine.” It can mean that ADHD has not been noticed, checked, or given enough useful support. Therapy, coaching, school help, or changes at work are also forms of care.

We also need to be honest about the evidence. Researchers cannot assign people to years without care just to watch what happens. Most long-term studies compare people who have ADHD with people who do not. They show higher risks, and they cannot prove that a lack of treatment caused each hard outcome.

A careful assessment matters. There is no single test that diagnoses ADHD. Many other problems can cause similar symptoms, including sleep disorders, anxiety, depression, and certain learning disabilities. A full evaluation includes a medical exam with hearing and vision testing to rule out other causes.2 A trained clinician looks at symptoms over time, in more than one setting, and at other possible explanations.137

Treatment can change the next step

Treatment cannot rewrite the past or promise perfect grades, a perfect job, or a conflict-free home. It can reduce symptoms, and some treatments improve parts of daily function. Long-term school, work, and relationship effects are less certain.

The American Academy of Pediatrics guideline sets out care by age:

• Ages 4 up to the sixth birthday: parent training in behavior management and behavioral classroom support come first. Methylphenidate may be considered if those steps do not bring significant improvement and the child’s difficulty remains moderate to severe.
• Ages 6 up to the twelfth birthday: an FDA-approved medication, along with parent training and behavioral classroom support. Both supports are preferred. School plans such as an IEP or a 504 plan belong here too.
• Ages 12 up to the eighteenth birthday: an FDA-approved medication with the teen’s own agreement, and training or behavioral interventions where available.37

Parent training does not mean parenting caused ADHD. It gives families tools for a child who needs more structure.

A 2024 U.S. federal review of 550 studies rated the evidence this way:

• high strength that medication improves core ADHD symptoms in children and teens
• moderate strength that medication improves daily function
• high strength that medication causes appetite loss and other side effects
• moderate strength that behavior-based treatment improves symptoms

It did not find any combination that was reliably better than a single approach.38

Quality of life is where the evidence splits, and it is worth saying so. One review pooled 17 randomized trials with 5,388 participants aged 6 and older. Amphetamines, methylphenidate, and atomoxetine each improved quality-of-life scores more than placebo. The effect sizes were moderate.39 A 2025 review focused on adults. It pooled 113 trials with 14,887 participants and reached a harder conclusion. Stimulants and atomoxetine were the only treatments with clear short-term benefit for core symptoms. The medications did not help on other outcomes, including quality of life. Most of those trials ran about 12 weeks. Longer-term evidence remains thin.40 Both reviews are careful work. Symptom relief is better established than life-quality change, especially in adults.

Care should be fitted to the person and checked over time. Benefits, appetite, sleep, mood, pulse, blood pressure, and other side effects need review. The goal is not to change who someone is. The goal is to make daily life safer, steadier, and less painful.37

What to bring to a first appointment

A good evaluation runs on information. Gathering these ahead of time shortens the path:

• report cards, progress reports, or teacher notes, going back as far as you have them
• recent work reviews or notes from a supervisor, for adults
• a short list of when the problems started and where they show up, at home, at school, at work, or with friends
• a description of a typical night of sleep, including bedtime, wake time, and snoring
• a list of other conditions, current medicines, supplements, alcohol use, and daily caffeine
• what you have already tried, and what helped even a little

If a school is involved, ask about an evaluation for an IEP or a 504 plan in writing. A written request starts a timeline.

One call can begin a different story

If ADHD may be affecting you or your child, the next step is a full evaluation with a qualified clinician. NP Fady offers a free 15-minute phone consultation for new patients, in the Redlands clinic or by telehealth across California. Call (909) 707-6261 or visit the ADHD care page.

Treatment is available and it starts with one phone call. ADHD does not affect only the person who has it. It reaches the people around them, whether that is a child’s family or an adult’s family. Asking for an evaluation is a small step, and it is often the one that changes the next year.

Frequently asked questions

Does untreated ADHD always lead to these problems?

No. These studies describe groups, not one person. They show higher risks on average, and they cannot prove that a lack of treatment caused each hard outcome.7 Care, support, and personal strengths can change what happens next.

Is it too late to get evaluated as an adult?

No. In a 2023 national survey, 55.9 percent of U.S. adults with an ADHD diagnosis were not diagnosed until age 18 or later.34 A late diagnosis is common, and it is not a failure.

Does ADHD medicine raise the risk of drug or alcohol problems later?

The evidence does not show that. One review pooled 15 long-term studies, and treated and untreated groups had similar later substance use.25 A later study found fewer substance-related emergency visits during medication periods than during off periods.26

What does untreated mean if we do not want medication?

Untreated does not simply mean no medicine. It can mean that ADHD has not been noticed, checked, or given enough useful support. Parent training, school plans, therapy, coaching, and changes at work are all forms of care.3738

Why does a good evaluation check for more than ADHD?

Most children with ADHD have at least one other condition, such as anxiety, a learning disability, or depression.35 Sleep disorders, anxiety, and depression can also cause similar symptoms, so a full evaluation rules those out before settling on an answer.237

Related reading on NP FADY

• ADHD Testing in the Inland Empire: a website-checked directory for children and adults
• Was It Anxiety, or Was ADHD Missed? ADHD in Women
• Change the Pattern, Not the Child: behavioral parent training for ADHD
• ADHD Workplace Accommodations: Do You Have to Disclose, and to Whom?

References

1. National Institute of Mental Health. “Attention-Deficit/Hyperactivity Disorder: What You Need to Know.” NIH Publication No. 24-MH-8300. Revised 2024. NIMH.

2. Centers for Disease Control and Prevention. “Diagnosing ADHD.” Last reviewed July 30, 2026. CDC.

3. Arnsten AFT. “Catecholamine Influences on Dorsolateral Prefrontal Cortical Networks.” Biological Psychiatry. 2011;69(12):e89-e99. PMID 21489408. PubMed.

4. MacDonald HJ, Kleppe R, Szigetvari PD, Haavik J. “The Dopamine Hypothesis for ADHD: An Evaluation of Evidence Accumulated From Human Studies and Animal Models.” Frontiers in Psychiatry. 2024;15:1492126. PMID 39619336. PubMed.

5. Shaw P, Eckstrand K, Sharp W, et al. “Attention-Deficit/Hyperactivity Disorder Is Characterized by a Delay in Cortical Maturation.” Proceedings of the National Academy of Sciences. 2007;104(49):19649-19654. PMID 18024590. Full text.

6. Norman LJ, Sudre G, Price J, Shaw P. “Subcortico-Cortical Dysconnectivity in ADHD: A Voxel-Wise Mega-Analysis Across Multiple Cohorts.” American Journal of Psychiatry. 2024;181(6):553-562. PMID 38476041. Full text.

7. Erskine HE, Norman RE, Ferrari AJ, et al. “Long-Term Outcomes of Attention-Deficit/Hyperactivity Disorder and Conduct Disorder: A Systematic Review and Meta-Analysis.” Journal of the American Academy of Child & Adolescent Psychiatry. 2016;55(10):841-850. PMID 27663939. PubMed.

8. Betancourt JL, Alderson RM, Roberts DK, Bullard CC. “Self-Esteem in Children and Adolescents With and Without Attention-Deficit/Hyperactivity Disorder: A Meta-Analytic Review.” Clinical Psychology Review. 2024;108:102394. PMID 38286088. PubMed.

9. Ros R, Graziano PA. “Social Functioning in Children With or At Risk for Attention Deficit/Hyperactivity Disorder: A Meta-Analytic Review.” Journal of Clinical Child & Adolescent Psychology. 2018;47(2):213-235. PMID 28128989. PubMed.

10. Spender K, Chen YR, Wilkes-Gillan S, Parsons L, Cantrill A, Simon M, et al. “The Friendships of Children and Youth With Attention-Deficit Hyperactivity Disorder: A Systematic Review.” PLOS ONE. 2023;18(8):e0289539. PMID 37549157. PubMed.

11. Theule J, Wiener J, Tannock R, Jenkins JM. “Parenting Stress in Families of Children With ADHD: A Meta-Analysis.” Journal of Emotional and Behavioral Disorders. 2013;21(1):3-17. DOI.

12. Pagespetit È, Pagerols M, Barrés N, et al. “ADHD and Academic Performance in College Students: A Systematic Review.” Journal of Attention Disorders. 2025;29(4):281-297. PMID 39668738. PubMed.

13. Boonstra AM, Oosterlaan J, Sergeant JA, Buitelaar JK. “Executive Functioning in Adult ADHD: A Meta-Analytic Review.” Psychological Medicine. 2005;35(8):1097-1108. PMID 16116936. PubMed.

14. Pievsky MA, McGrath RE. “The Neurocognitive Profile of Attention-Deficit/Hyperactivity Disorder: A Review of Meta-Analyses.” Archives of Clinical Neuropsychology. 2018;33(2):143-157. PMID 29106438. PubMed.

15. Fayyad J, Sampson NA, Hwang I, et al. “The Descriptive Epidemiology of DSM-IV Adult ADHD in the World Health Organization World Mental Health Surveys.” Attention Deficit and Hyperactivity Disorders. 2017;9(1):47-65. PMID 27866355. PubMed.

16. Gordon CT, Fabiano GA. “The Transition of Youth With ADHD Into the Workforce: Review and Future Directions.” Clinical Child and Family Psychology Review. 2019;22(3):316-347. PMID 30725305. PubMed.

17. Christiansen MS, Labriola M, Kirkeskov L, Lund T. “The Impact of Childhood Diagnosed ADHD Versus Controls Without ADHD Diagnoses on Later Labour Market Attachment: A Systematic Review of Longitudinal Studies.” Child and Adolescent Psychiatry and Mental Health. 2021;15(1):34. PMID 34162422. PubMed.

18. Pelham WE III, Page TF, Altszuler AR, Gnagy EM, Molina BSG, Pelham WE Jr. “The Long-Term Financial Outcome of Children Diagnosed With ADHD.” Journal of Consulting and Clinical Psychology. 2020;88(2):160-171. PMID 31789549. PubMed.

19. Wymbs BT, Canu WH, Sacchetti GM, Ranson LM. “Adult ADHD and Romantic Relationships: What We Know and What We Can Do to Help.” Journal of Marital and Family Therapy. 2021;47(3):664-681. PMID 33421168. PubMed.

20. Park JL, Hudec KL, Johnston C. “Parental ADHD Symptoms and Parenting Behaviors: A Meta-Analytic Review.” Clinical Psychology Review. 2017;56:25-39. PMID 28601690. PubMed.

21. Ruiz-Goikoetxea M, Cortese S, Aznarez-Sanado M, et al. “Risk of Unintentional Injuries in Children and Adolescents With ADHD and the Impact of ADHD Medications: A Systematic Review and Meta-Analysis.” Neuroscience & Biobehavioral Reviews. 2018;84:63-71. PMID 29162520. PubMed.

22. Chang Z, Lichtenstein P, D’Onofrio BM, Sjölander A, Larsson H. “Serious Transport Accidents in Adults With Attention-Deficit/Hyperactivity Disorder and the Effect of Medication: A Population-Based Study.” JAMA Psychiatry. 2014;71(3):319-325. PMID 24477798. PubMed.

23. Chang Z, Quinn PD, Hur K, et al. “Association Between Medication Use for Attention-Deficit/Hyperactivity Disorder and Risk of Motor Vehicle Crashes.” JAMA Psychiatry. 2017;74(6):597-603. PMID 28492937. PubMed.

24. Lee SS, Humphreys KL, Flory K, Liu R, Glass K. “Prospective Association of Childhood Attention-Deficit/Hyperactivity Disorder (ADHD) and Substance Use and Abuse/Dependence: A Meta-Analytic Review.” Clinical Psychology Review. 2011;31(3):328-341. PMID 21382538. PubMed.

25. Humphreys KL, Eng T, Lee SS. “Stimulant Medication and Substance Use Outcomes: A Meta-Analysis.” JAMA Psychiatry. 2013;70(7):740-749. PMID 23754458. PubMed.

26. Quinn PD, Chang Z, Hur K, et al. “ADHD Medication and Substance-Related Problems.” American Journal of Psychiatry. 2017;174(9):877-885. PMID 28659039. PubMed.

27. Dalsgaard S, Østergaard SD, Leckman JF, Mortensen PB, Pedersen MG. “Mortality in Children, Adolescents, and Adults With Attention Deficit Hyperactivity Disorder: A Nationwide Cohort Study.” The Lancet. 2015;385(9983):2190-2196. PMID 25726514. PubMed.

28. Li L, Zhu N, Zhang L, et al. “ADHD Pharmacotherapy and Mortality in Individuals With ADHD.” JAMA. 2024;331(10):850-860. PMID 38470385. PubMed.

29. Zhang L, Zhu N, Sjölander A, et al. “ADHD Drug Treatment and Risk of Suicidal Behaviours, Substance Misuse, Accidental Injuries, Transport Accidents, and Criminality: Emulation of Target Trials.” BMJ. 2025;390:e083658. PMID 40803836. PubMed.

30. National Institute for Health and Care Excellence. Attention Deficit Hyperactivity Disorder: Diagnosis and Management. NICE Guideline NG87. 2018, updated September 2019. NICE.

31. Cheung MMY, Hai T, Watkeys OJ, Laurens KR, Carr VJ, Green MJ. “Sex Differences in the Age at First Health Service Use for ADHD Among Australian Children.” Journal of Attention Disorders. Published online August 2026. PMID 42541370. PubMed.

32. Willcutt EG. “The Prevalence of DSM-IV Attention-Deficit/Hyperactivity Disorder: A Meta-Analytic Review.” Neurotherapeutics. 2012;9(3):490-499. PMID 22976615. PubMed.

33. Groenewald C, Emond A, Sayal K. “Recognition and Referral of Girls With Attention Deficit Hyperactivity Disorder: Case Vignette Study.” Child: Care, Health and Development. 2009;35(6):767-772. PMID 19531118. PubMed.

34. Staley BS, Robinson LR, Claussen AH, et al. “Attention-Deficit/Hyperactivity Disorder Diagnosis, Treatment, and Telehealth Use in Adults: National Center for Health Statistics Rapid Surveys System, United States, October-November 2023.” MMWR Morbidity and Mortality Weekly Report. 2024;73(40):890-895. PMID 39388378. CDC.

35. Danielson ML, Claussen AH, Bitsko RH, et al. “ADHD Prevalence Among U.S. Children and Adolescents in 2022: Diagnosis, Severity, Co-Occurring Disorders, and Treatment.” Journal of Clinical Child & Adolescent Psychology. 2024;53(3):343-360. PMID 38778436. PubMed.

36. Chung W, Jiang SF, Paksarian D, et al. “Trends in the Prevalence and Incidence of Attention-Deficit/Hyperactivity Disorder Among Adults and Children of Different Racial and Ethnic Groups.” JAMA Network Open. 2019;2(11):e1914344. PMID 31675080. Full text.

37. Wolraich ML, Hagan JF Jr, Allan C, et al. “Clinical Practice Guideline for the Diagnosis, Evaluation, and Treatment of Attention-Deficit/Hyperactivity Disorder in Children and Adolescents.” Pediatrics. 2019;144(4):e20192528. PMID 31570648. PubMed.

38. Peterson BS, Trampush J, Maglione M, et al. ADHD Diagnosis and Treatment in Children and Adolescents. Comparative Effectiveness Review No. 267. Agency for Healthcare Research and Quality; March 2024. AHRQ Publication No. 24-EHC003. NCBI Bookshelf.

39. Bellato A, Perrott NJ, Marzulli L, Parlatini V, Coghill D, Cortese S. “Systematic Review and Meta-Analysis: Effects of Pharmacological Treatment for Attention-Deficit/Hyperactivity Disorder on Quality of Life.” Journal of the American Academy of Child & Adolescent Psychiatry. 2025;64(3):346-361. PMID 38823477. PubMed.

40. Ostinelli EG, Schulze M, Zangani C, et al. “Comparative Efficacy and Acceptability of Pharmacological, Psychological, and Neurostimulatory Interventions for ADHD in Adults: A Systematic Review and Component Network Meta-Analysis.” The Lancet Psychiatry. 2025;12(1):32-43. PMID 39701638. PubMed.

This article is for education only. It is not a diagnosis or a substitute for care from a qualified health professional. If you or someone you know is in immediate danger, call 911. In the United States, call or text 988 for crisis support, or text HOME to 741741.

If you or someone you know is in crisis

• Call 911 or go to your nearest emergency room for any life-threatening emergency.
• 988 Suicide & Crisis Lifeline — call or text 988, or chat at 988lifeline.org, available 24/7, free and confidential. En español: marque 988 y oprima 2, o envíe AYUDA al 988. Deaf or hard of hearing: 988 videophone (ASL) or TTY 711 then 988. Veterans: 988 and press 1, or text 838255.
• Crisis Text Line — text HOME to 741741.
• The Trevor Project (crisis support for LGBTQ+ young people) — call 1-866-488-7386, or text START to 678-678.
• National Sexual Assault Hotline (RAINN) — call 1-800-656-HOPE (4673) or text HOPE to 64673; free, confidential, 24/7. Online chat at RAINN.org/hotline.
• National Domestic Violence Hotline — call 1-800-799-SAFE (7233) or text START to 88788; 24/7, help in 200+ languages. Online chat at TheHotline.org. If your phone or computer may be monitored, calling from a safer device is an option.
• Riverside County — Inland SoCal Crisis Helpline 951-686-HELP (4357), 24/7 (Inland SoCal United Way / 211+, in partnership with RUHS-BH); Community Access, Referral, Evaluation and Support (CARES) Line 800-499-3008, 24/7.
• San Bernardino County — Access Unit (Behavioral Health Helpline) 888-743-1478, 24/7; Mobile Crisis/CCRT 800-398-0018 (24/7, all ages) or text 909-420-0560. Arrowhead Regional Medical Center (ARMC) has a dedicated walk-in adolescent psychiatric ER (ages 13–17).
• Children under 13 — call 911 for immediate danger, contact your county's mobile crisis team (they respond to all ages), or go to the nearest pediatric emergency room.
• California Peer-Run Warm Line (non-crisis — someone to talk to) — call or text 1-855-600-WARM (9276); daytime and evening hours, not a 24/7 line.
• NP Fady (non-emergency) — for routine scheduling or questions, call (909) 707-6261. This line is not monitored for emergencies.